Green fluorescent protein as a selectable marker of retrovirally transduced hematopoietic progenitors

Akihiro Kume, Motohiro Hashiyama, Toshio Suda, Keiya Ozawa

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Recombinant retroviruses are most commonly used in hematopoietic stem cell gene therapy trials, but gene transfer efficiency is still inadequate with the present vectors. One approach for overcoming this problem is to develop methods of selecting and enriching the successfully transduced cells. We investigated the feasibility of using the green fluorescent protein (GFP) gene as a selectable marker of hematopoietic cells. When M1 murine leukemia cells were electroporated with GFP expression vectors, a red-shifted mutant (S65T) GFP showed several-fold greater fluorescence than the wild-type GFP and generated readily detectable green light under control of SRα or CAG promoter. We then inserted an SRα-S65T GFP cassette into the MSCV retrovirus vector and established virus producer cells. Infection of primary murine bone marrow cells resulted in a distinct population with green fluorescence, which was separated by fluorescence-activated cell sorting. The fractionated bright cells gave rise to fluorescent spleen colonies in lethally irradiated mice, while the fluorescence-negative cells yielded only dark colonies. These results indicated that GFP is a faithful marker in gene transfer into hematopoietic progenitor/stem cells, facilitating selection of the transduced cells and tracking of their progeny in vivo.

Original languageEnglish
Pages (from-to)226-232
Number of pages7
JournalStem Cells
Volume17
Issue number4
Publication statusPublished - 1999

Fingerprint

Green Fluorescent Proteins
Hematopoietic Stem Cells
Fluorescence
Retroviridae
Cell Tracking
Genes
Methyl Green
Cell- and Tissue-Based Therapy
Bone Marrow Cells
Genetic Therapy
Flow Cytometry
Leukemia
Spleen
Viruses
Infection
Population

Keywords

  • Flow cytometry
  • Gene therapy
  • Green fluorescent protein
  • Hematopoietic progenitor
  • Retrovirus vector
  • Selectable marker

ASJC Scopus subject areas

  • Cell Biology

Cite this

Kume, A., Hashiyama, M., Suda, T., & Ozawa, K. (1999). Green fluorescent protein as a selectable marker of retrovirally transduced hematopoietic progenitors. Stem Cells, 17(4), 226-232.

Green fluorescent protein as a selectable marker of retrovirally transduced hematopoietic progenitors. / Kume, Akihiro; Hashiyama, Motohiro; Suda, Toshio; Ozawa, Keiya.

In: Stem Cells, Vol. 17, No. 4, 1999, p. 226-232.

Research output: Contribution to journalArticle

Kume, A, Hashiyama, M, Suda, T & Ozawa, K 1999, 'Green fluorescent protein as a selectable marker of retrovirally transduced hematopoietic progenitors', Stem Cells, vol. 17, no. 4, pp. 226-232.
Kume, Akihiro ; Hashiyama, Motohiro ; Suda, Toshio ; Ozawa, Keiya. / Green fluorescent protein as a selectable marker of retrovirally transduced hematopoietic progenitors. In: Stem Cells. 1999 ; Vol. 17, No. 4. pp. 226-232.
@article{52183cfc935b4a22938abf62b65d73fa,
title = "Green fluorescent protein as a selectable marker of retrovirally transduced hematopoietic progenitors",
abstract = "Recombinant retroviruses are most commonly used in hematopoietic stem cell gene therapy trials, but gene transfer efficiency is still inadequate with the present vectors. One approach for overcoming this problem is to develop methods of selecting and enriching the successfully transduced cells. We investigated the feasibility of using the green fluorescent protein (GFP) gene as a selectable marker of hematopoietic cells. When M1 murine leukemia cells were electroporated with GFP expression vectors, a red-shifted mutant (S65T) GFP showed several-fold greater fluorescence than the wild-type GFP and generated readily detectable green light under control of SRα or CAG promoter. We then inserted an SRα-S65T GFP cassette into the MSCV retrovirus vector and established virus producer cells. Infection of primary murine bone marrow cells resulted in a distinct population with green fluorescence, which was separated by fluorescence-activated cell sorting. The fractionated bright cells gave rise to fluorescent spleen colonies in lethally irradiated mice, while the fluorescence-negative cells yielded only dark colonies. These results indicated that GFP is a faithful marker in gene transfer into hematopoietic progenitor/stem cells, facilitating selection of the transduced cells and tracking of their progeny in vivo.",
keywords = "Flow cytometry, Gene therapy, Green fluorescent protein, Hematopoietic progenitor, Retrovirus vector, Selectable marker",
author = "Akihiro Kume and Motohiro Hashiyama and Toshio Suda and Keiya Ozawa",
year = "1999",
language = "English",
volume = "17",
pages = "226--232",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Green fluorescent protein as a selectable marker of retrovirally transduced hematopoietic progenitors

AU - Kume, Akihiro

AU - Hashiyama, Motohiro

AU - Suda, Toshio

AU - Ozawa, Keiya

PY - 1999

Y1 - 1999

N2 - Recombinant retroviruses are most commonly used in hematopoietic stem cell gene therapy trials, but gene transfer efficiency is still inadequate with the present vectors. One approach for overcoming this problem is to develop methods of selecting and enriching the successfully transduced cells. We investigated the feasibility of using the green fluorescent protein (GFP) gene as a selectable marker of hematopoietic cells. When M1 murine leukemia cells were electroporated with GFP expression vectors, a red-shifted mutant (S65T) GFP showed several-fold greater fluorescence than the wild-type GFP and generated readily detectable green light under control of SRα or CAG promoter. We then inserted an SRα-S65T GFP cassette into the MSCV retrovirus vector and established virus producer cells. Infection of primary murine bone marrow cells resulted in a distinct population with green fluorescence, which was separated by fluorescence-activated cell sorting. The fractionated bright cells gave rise to fluorescent spleen colonies in lethally irradiated mice, while the fluorescence-negative cells yielded only dark colonies. These results indicated that GFP is a faithful marker in gene transfer into hematopoietic progenitor/stem cells, facilitating selection of the transduced cells and tracking of their progeny in vivo.

AB - Recombinant retroviruses are most commonly used in hematopoietic stem cell gene therapy trials, but gene transfer efficiency is still inadequate with the present vectors. One approach for overcoming this problem is to develop methods of selecting and enriching the successfully transduced cells. We investigated the feasibility of using the green fluorescent protein (GFP) gene as a selectable marker of hematopoietic cells. When M1 murine leukemia cells were electroporated with GFP expression vectors, a red-shifted mutant (S65T) GFP showed several-fold greater fluorescence than the wild-type GFP and generated readily detectable green light under control of SRα or CAG promoter. We then inserted an SRα-S65T GFP cassette into the MSCV retrovirus vector and established virus producer cells. Infection of primary murine bone marrow cells resulted in a distinct population with green fluorescence, which was separated by fluorescence-activated cell sorting. The fractionated bright cells gave rise to fluorescent spleen colonies in lethally irradiated mice, while the fluorescence-negative cells yielded only dark colonies. These results indicated that GFP is a faithful marker in gene transfer into hematopoietic progenitor/stem cells, facilitating selection of the transduced cells and tracking of their progeny in vivo.

KW - Flow cytometry

KW - Gene therapy

KW - Green fluorescent protein

KW - Hematopoietic progenitor

KW - Retrovirus vector

KW - Selectable marker

UR - http://www.scopus.com/inward/record.url?scp=0032813996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032813996&partnerID=8YFLogxK

M3 - Article

C2 - 10437986

AN - SCOPUS:0032813996

VL - 17

SP - 226

EP - 232

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

IS - 4

ER -